Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$16.95 - $27.04 $383,476 - $611,752
22,624 Added 346.3%
29,157 $788,000
Q1 2024

May 10, 2024

SELL
$11.38 - $19.03 $145,959 - $244,078
-12,826 Reduced 66.25%
6,533 $119,000
Q4 2023

Feb 09, 2024

BUY
$6.29 - $15.72 $116,761 - $291,810
18,563 Added 2332.04%
19,359 $237,000
Q3 2023

Nov 09, 2023

SELL
$14.99 - $32.65 $177,121 - $385,792
-11,816 Reduced 93.69%
796 $11,000
Q2 2023

Aug 10, 2023

BUY
$29.76 - $46.14 $346,823 - $537,715
11,654 Added 1216.49%
12,612 $409,000
Q1 2023

May 11, 2023

SELL
$38.09 - $57.79 $9,370 - $14,216
-246 Reduced 20.43%
958 $37,000
Q4 2022

Feb 09, 2023

SELL
$40.54 - $56.2 $12,851 - $17,815
-317 Reduced 20.84%
1,204 $63,000
Q3 2022

Nov 10, 2022

SELL
$36.98 - $49.2 $63,642 - $84,673
-1,721 Reduced 53.08%
1,521 $68,000
Q2 2022

Aug 10, 2022

BUY
$28.03 - $45.8 $21,246 - $34,716
758 Added 30.52%
3,242 $118,000
Q1 2022

May 12, 2022

SELL
$29.24 - $44.06 $208,218 - $313,751
-7,121 Reduced 74.14%
2,484 $103,000
Q4 2021

Feb 10, 2022

BUY
$39.32 - $61.61 $193,808 - $303,675
4,929 Added 105.41%
9,605 $409,000
Q3 2021

Nov 10, 2021

BUY
$44.0 - $65.8 $205,744 - $307,680
4,676 New
4,676 $257,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.